A new class of histamine H3 receptor antagonists derived from ligand based design
Design and synthesis of highly potent and selective non-imidazole inverse agonists for the histamine H(3) receptor is described. The study validates a new pharmacophore model based on the merging of two previously described models. It also demonstrates that the removal of the basic center potentiall...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 17; no. 13; pp. 3670 - 3675 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier
01.07.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0960-894X |
DOI | 10.1016/j.bmcl.2007.04.056 |
Cover
Summary: | Design and synthesis of highly potent and selective non-imidazole inverse agonists for the histamine H(3) receptor is described. The study validates a new pharmacophore model based on the merging of two previously described models. It also demonstrates that the removal of the basic center potentially interacting with ASP3.32 and common to both models leads to loss of activity, whereas the replacement of the second basic center by an acceptor retains the potency. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X |
DOI: | 10.1016/j.bmcl.2007.04.056 |